Showing results (291-300 of 396) with videos related to
Sort By:
Pageof 40
Brain Pathology (Zurich, Switzerland)|October 5, 2017
Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular featuresFranck Bielle, Anna-Luisa Di Stefano, David Meyronet, et al.Journal of Neuro-Oncology|March 5, 2014
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomasEmeline Gillet, Agusti Alentorn, Brahima Doukouré, et al.Neuro-Oncology|November 11, 2020
IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratificationGiulia Berzero, Anna Luisa Di Stefano, Susanna Ronchi, et al.Molecular Cancer|September 9, 2010
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patientsFrançois Ducray, Aurélien de Reyniès, Olivier Chinot, et al.Journal of Cancer Survivorship : Research and Practice|May 4, 2023
Late-onset vascular complications of radiotherapy for primary brain tumors: a case-control and cross-sectional analysisMaría-José Ibáñez-Juliá, Alberto Picca, Delphine Leclercq, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2026
18F-DOPA-PET and advanced MRI improve treatment response assessment in IDH1/2-mutant gliomas treated with IDH inhibitorsDiego Prost, Lucia Nichelli, Laura Rozenblum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2008
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie CellulaireCarole Soussain, Khê Hoang-Xuan, Luc Taillandier, et al.The Oncologist|July 27, 2019
Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway AlterationsWilliam Boisseau, Philipp Euskirchen, Karima Mokhtari, et al.Clinical Neurology and Neurosurgery|June 20, 2020
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastomaAntoine Seyve, Fernando Lozano-Sanchez, Alice Thomas, et al.Neuro-Oncology|December 17, 2013
Clinical value of chromosome arms 19q and 11p losses in low-grade gliomasAgustí Alentorn, Hinke F van Thuijl, Yannick Marie, et al.Pageof 40